Develop and validate insect cell-based assays and disease models for drug screening and functional studies.
From target expression to validated functional assays, we provide end-to-end support for screening and modeling using Sf9, Sf21, or Hi5 cells.
We combine insect cell culture expertise with flexible assay design to build robust, reproducible models for your drug discovery pipeline.
Transient expression of target proteins or reporters uses baculovirus infection or plasmid transfection; stable expression workflows use plasmid transfection, selection, and clonal isolation.
Development and optimization of cell-based assays using plate-reader or imaging readouts, including signal-to-background optimization, Z′ factor calculation, and reproducibility testing.
Project scope is defined by your target, desired readout, and model complexity. We adapt cell lines, assay conditions, and throughput to meet your specific needs.
Cell health monitoring, assay reproducibility checks, and positive/negative controls are built into every project. Data are reviewed at key milestones with documented acceptance criteria.
Deliverables include raw data, analysis reports, validated protocols, and materials (cell banks, plasmids) where scoped, ensuring you can replicate or further develop the model.
Each project delivers a defined package of data, materials, and documentation to support your downstream decisions.
Each project is scoped individually. Below are typical parameters that can be tailored during the initial consultation.
| Parameter | Typical project scope |
|---|---|
| Cell Host | Sf9, Sf21, Hi5, or other insect cell lines; client-provided or sourced |
| Gene/Target | Sequence provided by client; codon optimization for insect cells |
| Assay Format | Luminescence (e.g., luciferase reporter), fluorescence (e.g., GFP, FRET), high-content imaging, or absorbance |
| Readout Type | Endpoint, kinetic, or multiplexed; plate-reader or automated microscopy |
| Throughput Level | From low (96-well) to high (384-well); number of compounds/replicates specified per study |
| QC & Validation | Cell viability, mycoplasma testing, assay robustness (Z′ factor), and positive/negative controls |
A structured, milestone-driven engagement from consultation to validated assay delivery.
We discuss your target, desired readout, and model requirements to define scope, timeline, and acceptance criteria. Inputs include sequence, assay goal, and any existing protocols.
Plasmid transfection can support transient or stable expression, while baculovirus infection is normally used for transient production. Stable-line workflows include selection and clonal isolation.
We evaluate cell density, induction conditions, reagent concentrations, and readout parameters to evaluate signal-to-noise and assay window. Pilot experiments confirm reproducibility.
The optimized assay is tested with reference compounds or controls to investigate Z′ factor, dynamic range, and intra-plate variability. Acceptance criteria are compared against project goals.
Raw data are processed, dose-response curves fitted (e.g., four-parameter logistic), and results compiled into a final report with the supporting data.
Insect cell-based assays are widely used in early drug discovery and functional genomics.
Develop robust cell-based assays for primary and secondary screening of small molecules, natural products.
Express relevant receptors or signaling components in insect cells to model pathways such as GPCR, ion channel, or kinase cascades.
Use insect cell models to evaluate cytotoxicity, genotoxicity, or off-target effects in early safety profiling.
Common questions about our insect cell assay and modeling services.
We routinely work with Sf9, Sf21, and Hi5 cells. Other insect cell lines can be accommodated as scoped. The choice depends on your target expression requirements, glycosylation preferences, and assay format.
Assay reproducibility is assessed through intra- and inter-plate variability testing, calculation of Z′ factor using positive and negative controls, and inclusion of control wells on every plate. We also monitor cell health and passage number during the project.
We support luminescence (e.g., luciferase), fluorescence (e.g., GFP, FRET, TR-FRET), absorbance, and high-content imaging readouts. The optimal format is selected during consultation based on target biology and desired throughput.
Yes. Transient expression using baculovirus or plasmid transfection is fast and suitable for screening. Stable cell lines (via selection and clonal isolation) are available for longer-term studies where consistent expression is critical. Timelines depend on the approach chosen.
Get a customized quote for your Insect Cell-Based Assay and Modeling Services project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.